11 November 2025
Linklaters advises Jacobs Capital on the disposal of Stingray Healthcare to Amethyst Radiotherapy
Advising firms
Deal team
9 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Ben Rodham Lead | Linklaters | Partner | Private Equity | London |
| Martin Arnal | Linklaters | Senior associate | Not stated | London |
| Louisa Pratt | Linklaters | Associate | Not stated | London |
| Jamie Coomber | Linklaters | Partner | Tax | Not stated |
| Thomas Waller | Linklaters | Partner | Leveraged Finance | Not stated |
| Neil Hoolihan | Linklaters | Partner | Antitrust | Brussels |
| Karolis Pocius | Linklaters | Senior associate | Not stated | Brussels |
| Maxime Bertomeu-Savalle | Linklaters | Counsel | Corporate | Luxembourg |
| Aurélie Mounier | Linklaters | Senior associate | Not stated | Luxembourg |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Jacobs CapitalSell-side
- Counterparties
- Amethyst Radiotherapy (Buy-side)
Fremman Capital (Investor)